Seth Sandesh
Actinium Pharmaceuticals, Inc. · Chief Executive Officer
Seth Sandesh is listed in filings as Chief Executive Officer at Actinium Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Aug 20, 2025, including 9 public disclosures. Recent filings connect the profile to Actinium Pharmaceuticals, Inc. (ATNM). The current snapshot covers public activity from Apr 2, 2025 to Aug 20, 2025. Reported amounts are shown as $206.7K to $4.1M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||